Get started
Author

Mingjun Shi

Observed names: M. Shi, MINGJUN SHI, Ming-Jun SHI, Ming-Jun Shi, Ming‐Jun Shi, SHI, Ming-Jun, Shi Ming-Jun, Shi, Ming-Jun, Shi, Mingjun, 石铭俊
Institutions: Centre National de la Recherche Scientifique, Capital Medical University, Université Paris Sciences et Lettres, Sorbonne Université, Beijing Municipal Health Commission, Beijing Friendship Hospital, Biologie cellulaire et Cancer, Institut Curie
Observed institutions: Université Paris-Sud, Centre National de la Recherche Scientifique, Capital Medical University, Université Paris Sciences et Lettres, Université Paris-Saclay, Wuhan University, Sorbonne Université, La Ligue Contre le Cancer, Zhongnan Hospital of Wuhan University, Beijing Municipal Health Commission, Beijing Friendship Hospital, Biologie cellulaire et Cancer, Université Pierre-et-Marie-Curie, Institut Curie
ORCID: 0000-0002-5927-5493
Observed ORCID: 0000-0002-5927-5493
OpenAlex ID: A5101866587
Sleep duration and risk of all-cause mortality: A flexible, non-linear, meta-regression of 40 prospective cohort studies
2016 · Tong-Zu Liu, Chang Xu, et al. · Sleep Medicine Reviews · 300
Loss of the Mouse Ortholog of the Shwachman-Diamond Syndrome Gene (Sbds) Results in Early Embryonic Lethality
2006 · Siyi Zhang, Mingjun Shi, et al. · Molecular and Cellular Biology · 122
An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers
2018 · Mélanie Mahe, Florent Dufour, et al. · EMBO Molecular Medicine · 97
PDF
Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer
2020 · Ming-Jun Shi, Xiang-Yu Meng, et al. · Genome Medicine · 59
PDF
APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer
2019 · Ming-Jun Shi, Xiang-Yu Meng, et al. · European Urology · 57
ABC294640, a sphingosine kinase 2 inhibitor, enhances the antitumor effects of TRAIL in non-small cell lung cancer
2015 · Jie Yang, Chunxu Yang, et al. · Cancer Biology & Therapy · 53
PDF
The Role of COL5A2 in Patients With Muscle-Invasive Bladder Cancer: A Bioinformatics Analysis of Public Datasets Involving 787 Subjects and 29 Cell Lines
2019 · Xiang-Yu Meng, Ming-Jun Shi, et al. · Frontiers in Oncology · 48
PDF
Anti-tumor activity of the TRPM8 inhibitor BCTC in prostate cancer DU145 cells
2015 · TAO LIU, ZHIHAI FANG, et al. · Oncology Letters · 36
PDF
High CD3D/CD4 ratio predicts better survival in muscle-invasive bladder cancer
2019 · Ming-Jun Shi, Xiang-Yu Meng, et al. · Cancer Management and Research · 35
PDF
Intrafascial versus interfascial nerve sparing in radical prostatectomy for localized prostate cancer: a systematic review and meta-analysis
2017 · Hong Weng, Xian-Tao Zeng, et al. · Scientific Reports · 30
PDF
Proteogenomic Characterization of Bladder Cancer Reveals Sensitivity to Apoptosis Induced by Tumor Necrosis Factor–related Apoptosis-inducing Ligand in FGFR3-mutated Tumors
2023 · Clarice S. Groeneveld, Virginia Sanchez-Quiles, et al. · European Urology · 29
FGFR3 Mutational Activation Can Induce Luminal-like Papillary Bladder Tumor Formation and Favors a Male Sex Bias
2022 · Ming-Jun Shi, Jacqueline Fontugne, et al. · European Urology · 28
PDF
Integrated Analysis of the Fecal Metagenome and Metabolome in Bladder Cancer in a Chinese Population
2022 · Chuan Qin, Zhenghao Chen, et al. · Genes · 27
PDF
Concurrent cisplatin-based chemoradiotherapy versus exclusive radiotherapy in high-risk cervical cancer: a meta-analysis
2016 · Xiangyu Meng, Yi Liao, et al. · OncoTargets and Therapy · 25
PDF
Systematic review and meta-analysis on phosphodiesterase 5 inhibitors and α-adrenoceptor antagonists used alone or combined for treatment of LUTS due to BPH
2015 · Xing-Huan Wang, Xin-Hua Zhang, et al. · Asian Journal of Andrology · 25
Porous Se@SiO2 Nanoparticles Enhance Wound Healing by ROS-PI3K/Akt Pathway in Dermal Fibroblasts and Reduce Scar Formation
2022 · Bo-Yu Yang, Zhi-Yuan Zhou, et al. · Frontiers in Bioengineering and Biotechnology · 22
PDF
Machine Learning-Based Detection of Bladder Cancer by Urine cfDNA Fragmentation Hotspots that Capture Cancer-Associated Molecular Features
2024 · Xiang-Yu Meng, Xiong-Hui Zhou, et al. · Clinical Chemistry · 18
PDF
Circulating tumor cells in breast cancer and its association with tumor clinicopathological characteristics: a meta-analysis
2014 · Yi Liao, Shu-Yi Wang, et al. · Medical Oncology · 18
Alteration of pro-carcinogenic gut microbiota is associated with clear cell renal cell carcinoma tumorigenesis
2023 · Bo-Yu Yang, Fang-Zhou Zhao, et al. · Frontiers in Microbiology · 17
A Novel tiRNA-Gly-GCC-1 Promotes Progression of Urothelial Bladder Carcinoma and Directly Targets TLR4
2022 · Chuan Qin, Zheng-Hao Chen, et al. · Cancers · 16
PDF
Differential Expression Profiles and Bioinformatics Analysis of tRNA-Derived Small RNAs in Muscle-Invasive Bladder Cancer in a Chinese Population
2022 · Chuan Qin, Zheng-Hao Chen, et al. · Genes · 14
PDF
Association between the TACC3 rs798766 Polymorphism and Risk of Urinary Bladder Cancer: A Synthesis Based on Current Evidence
2017 · Xiang-Yu Meng, Ming-Jun Shi, et al. · Disease Markers · 10
PDF
Bladder neck contracture following transurethral surgery of prostate: a retrospective single-center study
2024 · Meng-Hua Wu, Jia-Xin Liu, et al. · World Journal of Urology · 9
Establishment of a novel prognostic prediction model through bioinformatics analysis for prostate cancer based on ferroptosis-related genes and its application in immune cell infiltration
2022 · Bo-Yu Yang, Mei-Shan Zhao, et al. · Translational Andrology and Urology · 8
PDF
The Role of STEAP1 in Prostate Cancer: Implications for Diagnosis and Therapeutic Strategies
2025 · Lingling Zhang, Xinyi Ren, et al. · Biomedicines · 6
Works count: 67
Citation count: 1,145
H-index: 18
I10-index: 22
Year
Topic
Type